At 30 days, a moderate labeling for osteoprotegerin is observed, with remnant of non-mineralized extracellular matrix, once again showing a delay in the repair stage when compared to the BC-N group for the same period. The gene discussed is TNFRSF11B; the disease is breast cancer.